{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:19:47Z","timestamp":1792801187517,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"project of Administration of Traditional Chinese Medicine of Jiangsu Province of China","award":["MS2022066"],"award-info":[{"award-number":["MS2022066"]}]},{"DOI":"10.13039\/501100016355","name":"Xuzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["KC23220"],"award-info":[{"award-number":["KC23220"]}],"id":[{"id":"10.13039\/501100016355","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xuzhou Health Commission","award":["XWKYHT20220137"],"award-info":[{"award-number":["XWKYHT20220137"]}]},{"name":"Development Fund of the Affiliated Hospital of Xuzhou Medical University","award":["XYFY202235"],"award-info":[{"award-number":["XYFY202235"]}],"id":[{"id":"https:\/\/ror.org\/02kstas42","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Affiliated Xuzhou Eastern Hospital of Xuzhou Medical University","award":["2022009"],"award-info":[{"award-number":["2022009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06290-z","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T07:11:30Z","timestamp":1741072290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["EMB-driven glioblastoma multiforme progression via the MCT4\/GPX3 axis: therapeutic inhibition by Ganxintriol A"],"prefix":"10.1186","volume":"23","author":[{"given":"Bo","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"2","key":"6290_CR1","first-page":"76","volume":"45","author":"R Huang","year":"1990","unstructured":"Huang R, Ozawa M, Kadomatsu K, Muramatsu T. Developmentally regulated expression of embigin, a member of the immunoglobulin superfamily found in embryonal carcinoma cells. Diff Res Biol Div. 1990;45(2):76\u201383.","journal-title":"Diff Res Biol Div"},{"issue":"2","key":"6290_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.1993.1030","volume":"155","author":"R Huang","year":"1993","unstructured":"Huang R, Ozawa M, Kadomatsu K, Muramatsu T. Embigin, a member of the immunoglobulin superfamily expressed in embryonic cells, enhances cell-substratum adhesion. Dev Biol. 1993;155(2):307\u201314.","journal-title":"Dev Biol"},{"issue":"2","key":"6290_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0378-1119(99)00445-X","volume":"240","author":"H Tachikui","year":"1999","unstructured":"Tachikui H, Kurosawa N, Kadomatsu K, Muramatsu T. Genomic organization and promoter activity of embigin, a member of the immunoglobulin superfamily. Gene. 1999;240(2):325\u201332.","journal-title":"Gene"},{"issue":"3\u20134","key":"6290_CR4","first-page":"95","volume":"57","author":"T Muramatsu","year":"1994","unstructured":"Muramatsu T. Cell surface glycoproteins: biochemical, immunological and molecular biological studies. Nagoya J Med Sci. 1994;57(3\u20134):95\u2013108.","journal-title":"Nagoya J Med Sci"},{"issue":"13","key":"6290_CR5","doi-asserted-by":"publisher","first-page":"8930","DOI":"10.1074\/jbc.M809491200","volume":"284","author":"E Lain","year":"2009","unstructured":"Lain E, Carnejac S, Escher P, Wilson M, L\u00f8mo T, Gajendran N, et al. A novel role for embigin to promote sprouting of motor nerve terminals at the neuromuscular junction. J Biol Chem. 2009;284(13):8930\u20139.","journal-title":"J Biol Chem"},{"issue":"5","key":"6290_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/mc.22309","volume":"55","author":"D Jung","year":"2016","unstructured":"Jung D, Kim J, Kim C, Song S. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-\u03b2 pathway. Mol Carcinog. 2016;55(5):633\u201345.","journal-title":"Mol Carcinog"},{"issue":"7","key":"6290_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/cancers10070239","volume":"10","author":"IMW Ruma","year":"2018","unstructured":"Ruma IMW, Kinoshita R, Tomonobu N, Inoue Y, Kondo E, Yamauchi A, et al. Embigin promotes prostate cancer progression by S100A4-dependent and-independent mechanisms. Cancers (Basel). 2018;10(7):239.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6290_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","volume":"26","author":"RA Vaubel","year":"2020","unstructured":"Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, et al. Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma. Clin Cancer Res. 2020;26(5):1094\u2013104.","journal-title":"Clin Cancer Res"},{"key":"6290_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind J. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"issue":"29","key":"6290_CR10","doi-asserted-by":"publisher","first-page":"27213","DOI":"10.1074\/jbc.M411950200","volume":"280","author":"M Wilson","year":"2005","unstructured":"Wilson M, Meredith D, Fox J, Manoharan C, Davies A, Halestrap A. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005;280(29):27213\u201321.","journal-title":"J Biol Chem"},{"key":"6290_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12935-019-0889-8","volume":"19","author":"C Guo","year":"2019","unstructured":"Guo C, Huang T, Wang Q, Li H, Khanal A, Kang E, et al. Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells. Cancer Cell Int. 2019;19:170.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"6290_CR12","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/carcin\/bgs196","volume":"33","author":"X Ke","year":"2012","unstructured":"Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q, et al. Hypoxia upregulates CD147 through a combined effect of HIF-1\u03b1 and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis. 2012;33(8):1598\u2013607.","journal-title":"Carcinogenesis"},{"issue":"9","key":"6290_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-022-05219-4","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Song J, Dong W, Liu X, Yang C, Wang D, et al. The MBNL1\/circNTRK2\/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa. Cell Death Dis. 2022;13(9):767.","journal-title":"Cell Death Dis"},{"issue":"8","key":"6290_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41419-022-05175-z","volume":"13","author":"K Luo","year":"2022","unstructured":"Luo K, Liu A, Wu H, Liu Q, Dai J, Liu Y, et al. CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis. Cell Death Dis. 2022;13(8):740.","journal-title":"Cell Death Dis"},{"issue":"17","key":"6290_CR15","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41388-020-1235-2","volume":"39","author":"A Khan","year":"2020","unstructured":"Khan A, Valli E, Lam H, Scott D, Murray J, Hanssen K, et al. Targeting metabolic activity in high-risk neuroblastoma through monocarboxylate transporter 1 (MCT1) inhibition. Oncogene. 2020;39(17):3555\u201370.","journal-title":"Oncogene"},{"issue":"10","key":"6290_CR16","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","volume":"1863","author":"J Perez-Escuredo","year":"2016","unstructured":"Perez-Escuredo J, Van Hee VF, Sboarina M, Falces J, Payen VL, Pellerin L, et al. Monocarboxylate transporters in the brain and in cancer. Biochem Biophys Acta. 2016;1863(10):2481\u201397.","journal-title":"Biochem Biophys Acta"},{"key":"6290_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/972913","volume":"2013","author":"N Traverso","year":"2013","unstructured":"Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013: 972913.","journal-title":"Oxid Med Cell Longev"},{"key":"6290_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156070","volume":"135","author":"T Sun","year":"2024","unstructured":"Sun T, Lin B, Sun Q, Zhang X, Wang T, Yang J, et al. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1. Phytomedicine. 2024;135: 156070.","journal-title":"Phytomedicine"},{"key":"6290_CR19","doi-asserted-by":"publisher","first-page":"21835","DOI":"10.1038\/s41598-023-48777-z","volume":"13","author":"S Zhu","year":"2023","unstructured":"Zhu S, Guo J, Yu L, Liu J, Chen J, Xin J, et al. Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells. Sci Rep. 2023;13:21835.","journal-title":"Sci Rep"},{"key":"6290_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/DDDT.S132488","volume":"11","author":"F Ke","year":"2017","unstructured":"Ke F, Wang Z, Song X, Ma Q, Hu Y, Jiang L, et al. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NF\u03baB pathways in cholangiocarcinoma cells. Drug Des Devel Ther. 2017;11:1753\u201366.","journal-title":"Drug Des Devel Ther"},{"key":"6290_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118281","volume":"331","author":"J Bai","year":"2024","unstructured":"Bai J, Qin Q, Li S, Cui X, Zhong Y, Yang L, et al. Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression. J Ethnopharmacol. 2024;331: 118281.","journal-title":"J Ethnopharmacol"},{"key":"6290_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.837055","volume":"13","author":"P Cai","year":"2022","unstructured":"Cai P, Sheng G, Jiang S, Wang D, Zhao Z, Huang M, et al. Comparative proteomics analysis reveals the reversal effect of cryptotanshinone on gefitinib-resistant cells in epidermal growth factor receptor-mutant lung cancer. Front Pharmacol. 2022;13: 837055.","journal-title":"Front Pharmacol"},{"key":"6290_CR23","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1080\/14786419.2021.1906666","volume":"36","author":"B Qiu","year":"2022","unstructured":"Qiu B, Wang P, Li J. Salvia przewalskii Salprzesides A and B: two novel icetexane diterpenes with antiangiogenic activity from Maxim. Nat Prod Res. 2022;36:2479\u201385.","journal-title":"Nat Prod Res"},{"issue":"3","key":"6290_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/molecules27030657","volume":"27","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang M, Fang J, He Y, Liu M, Hong Z, et al. Salvia miltiorrhiza simultaneous determination of seven lipophilic and hydrophilic components in bunge by LC-MS\/MS method and its application to a transport study in a blood-brain-barrier cell model. Molecules. 2022;27(3):657.","journal-title":"Molecules"},{"key":"6290_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105661","volume":"169","author":"L Subedi","year":"2021","unstructured":"Subedi L, Gaire BP. Tanshinone IIA: a phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res. 2021;169: 105661.","journal-title":"Pharmacol Res"},{"key":"6290_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116398","volume":"226","author":"T Zhang","year":"2024","unstructured":"Zhang T, Pan W, Tan X, Yu J, Cheng S, Wei S, et al. A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K\/AKT pathway. Biochem Pharmacol. 2024;226: 116398.","journal-title":"Biochem Pharmacol"},{"key":"6290_CR27","unstructured":"The Human Protein Atlas. Sweden. http:\/\/proteinatlas.org\/. Accessed 22 Jun 2024."},{"key":"6290_CR28","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"6290_CR29","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"T Zefang","year":"2019","unstructured":"Zefang T, Boxi K, Chenwei L, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"6290_CR30","unstructured":"STRING, Protein network of EMB, https:\/\/cn.string-db.org\/cgi\/network?taskId=beJ1VXVeDkfC&sessionId=bQz7I0J6EzEr, Accessed 15 Sep 2024."},{"key":"6290_CR31","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"S Vasaikar","year":"2018","unstructured":"Vasaikar S, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6290_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4149\/gpb_2018030","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients. GPB. 2021;19(1):1\u201312.","journal-title":"GPB"},{"key":"6290_CR33","unstructured":"The Human Protein Atlas, Brain single cell expression of EMB, https:\/\/www.proteinatlas.org\/ENSG00000170571-EMB\/tissue, Accessed 22 Jun 2024."},{"key":"6290_CR34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407279","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015. https:\/\/doi.org\/10.1056\/NEJMoa1407279.","journal-title":"N Engl J Med"},{"key":"6290_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12916-024-03775-4","volume":"22","author":"T Duraj","year":"2024","unstructured":"Duraj T, Kalamian M, Zuccoli G, Maroon JC, D\u2019Agostino DP, Scheck AC, et al. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med. 2024;22:578.","journal-title":"BMC Med"},{"key":"6290_CR36","doi-asserted-by":"crossref","unstructured":"Zhou Z, Yin X, Sun H, Lu J, Li Y, Fan Y, et al. PTBP1 lactylation promotes glioma stem cell maintenance through PFKFB4-driven glycolysis. Cancer Res, 2024, undefined.","DOI":"10.1158\/0008-5472.c.7676157"},{"issue":"20","key":"6290_CR37","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1111\/febs.16024","volume":"288","author":"A K\u00f6pnick","year":"2021","unstructured":"K\u00f6pnick A, Geistlinger K, Beitz E. Cysteine 159 delineates a hinge region of the alternating access monocarboxylate transporter 1 and is targeted by cysteine-modifying inhibitors. FEBS J. 2021;288(20):6052\u201362.","journal-title":"FEBS J"},{"key":"6290_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fcell.2020.00651","volume":"8","author":"X Sun","year":"2020","unstructured":"Sun X, Wang M, Wang M, Yao L, Li X, Dong H, et al. Role of proton-coupled monocarboxylate transporters in cancer: from metabolic crosstalk to therapeutic potential. Front Cell Dev Biol. 2020;8:651.","journal-title":"Front Cell Dev Biol"},{"key":"6290_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Cancer. 2021;2:271\u201383.","journal-title":"Nat Cancer"},{"key":"6290_CR40","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-05-1173","volume":"65","author":"SL Holmen","year":"2005","unstructured":"Holmen SL, Williams BO. Essential role for Ras signaling in glioblastoma maintenance. Cancer Res. 2005;65:8250\u20135.","journal-title":"Cancer Res"},{"key":"6290_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/07357907.2011.630050","volume":"30","author":"H Mao","year":"2012","unstructured":"Mao H, Lebrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest. 2012;30:48\u201356.","journal-title":"Cancer Invest"},{"issue":"2\u20133","key":"6290_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","volume":"34","author":"AP Halestrap","year":"2013","unstructured":"Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med. 2013;34(2\u20133):337\u201349.","journal-title":"Mol Aspects Med"},{"key":"6290_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.933071","volume":"12","author":"W Ren","year":"2022","unstructured":"Ren W, Yuan Y, Chen X, Zhai H, An Y, Tang L, et al. Identification and validation of long non-coding RNA LCIIAR as a biomarker in LUAD. Front Oncol. 2022;12: 933071.","journal-title":"Front Oncol"},{"issue":"6","key":"6290_CR44","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s13402-021-00643-8","volume":"44","author":"S Lee","year":"2021","unstructured":"Lee S, Hwang H, Lee W, Kang C. MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer. Cell Oncol. 2021;44(6):1363\u201371.","journal-title":"Cell Oncol"},{"key":"6290_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.950886","volume":"13","author":"Z Feng","year":"2022","unstructured":"Feng Z, Ou Y, Hao L. The roles of glycolysis in osteosarcoma. Front Pharmacol. 2022;13: 950886.","journal-title":"Front Pharmacol"},{"key":"6290_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100822","volume":"61","author":"M Pi","year":"2022","unstructured":"Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, et al. Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resist Updat. 2022;61: 100822.","journal-title":"Drug Resist Updat"},{"key":"6290_CR47","doi-asserted-by":"publisher","first-page":"4081380","DOI":"10.1155\/2022\/4081380","volume":"2022","author":"H Lin","year":"2022","unstructured":"Lin H, Lim S, Hsu T, Yang W, Huang C, Tsai Y, et al. CCAAT\/enhancer-binding protein delta regulates glioblastoma survival through catalase-mediated hydrogen peroxide clearance. Oxid Med Cell Longev. 2022;2022:4081380.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"6290_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jnc.14250","volume":"144","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Du S, Du Y, Ren J, Ying G, Yan Z. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. J Neurochem. 2018;144(1):93\u2013104.","journal-title":"J Neurochem"},{"issue":"6","key":"6290_CR49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/15384047.2017.1323583","volume":"18","author":"LR Oancea-Castillo","year":"2017","unstructured":"Oancea-Castillo LR, Klein C, Abdollahi A, Weber KJ, Regnier-Vigouroux A, Dokic I. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines. Cancer Biol Ther. 2017;18(6):400\u20136.","journal-title":"Cancer Biol Ther"},{"key":"6290_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841418","volume":"12","author":"H Kram","year":"2022","unstructured":"Kram H, Prokop G, Haller B, Gempt J, Wu Y, Schmidt-Graf F, et al. Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis. Front Oncol. 2022;12: 841418.","journal-title":"Front Oncol"},{"issue":"1","key":"6290_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12967-020-02420-x","volume":"18","author":"ML Zhang","year":"2020","unstructured":"Zhang ML, Wu HT, Chen WJ, Xu Y, Ye QQ, Shen JX, et al. Involvement of glutathione peroxidases in the occurrence and development of breast cancers. J Transl Med. 2020;18(1):247.","journal-title":"J Transl Med"},{"issue":"5","key":"6290_CR52","first-page":"906","volume":"29","author":"Y Huang","year":"2012","unstructured":"Huang Y, Fang W, Wang Y, Yang W, Xiong B. Transforming growth factor-\u03b21 induces glutathione peroxidase-1 and protects from H2O2-induced cell death in colon cancer cells via the Smad2\/ERK1\/2\/HIF-1\u03b1 pathway. Int J Mol Med. 2012;29(5):906\u201312.","journal-title":"Int J Mol Med"},{"issue":"6","key":"6290_CR53","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.0906-6705.2005.00296.x","volume":"14","author":"S Mouret","year":"2005","unstructured":"Mouret S, Sauvaigo S, Peinnequin A, Favier A, Beani JC, Leccia MT. E6* oncoprotein expression of human papillomavirus type-16 determines different ultraviolet sensitivity related to glutathione and glutathione peroxidase antioxidant defence. Exp Dermatol. 2005;14(6):401\u201310.","journal-title":"Exp Dermatol"},{"key":"6290_CR54","first-page":"983","volume":"45","author":"S Jian","year":"2020","unstructured":"Jian S, Chen L, Minxue L, Hongmin C, Ronghua T, Xiaoxuan F, et al. Tanshinone I induces apoptosis and protective autophagy in human glioblastoma cells via a reactive oxygen species-dependent pathway. Int J Mol Med. 2020;45:983\u201392.","journal-title":"Int J Mol Med"},{"key":"6290_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41420-023-01462-6","volume":"9","author":"J Schaf","year":"2023","unstructured":"Schaf J, Shinhmar S, Zeng Q, Pardo OE, Beesley P, Syed N, et al. Enhanced sestrin expression through tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth. Cell Death Discov. 2023;9:172.","journal-title":"Cell Death Discov"},{"key":"6290_CR56","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.2147\/CMAR.S256347","volume":"12","author":"S You","year":"2020","unstructured":"You S, He X, Wang M, Mao L, Zhang L. Tanshinone IIA suppresses glioma cell proliferation, migration and invasion both in vitro and in vivo partially through miR-16-5p\/Talin-1 (TLN1) axis. Cancer Manag Res. 2020;12:11309\u201320.","journal-title":"Cancer Manag Res"},{"key":"6290_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2021.02.014","volume":"166","author":"B Zhong","year":"2021","unstructured":"Zhong B, Yu J, Hou Y, Ai N, Ge W, Lu JJ, et al. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radic Biol Med. 2021;166:104\u201315.","journal-title":"Free Radic Biol Med"},{"key":"6290_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3892\/ol.2022.13304","volume":"23","author":"H Qi","year":"2022","unstructured":"Qi H, Chen Z, Qin Y, Wang X, Zhang Z, Li Y. Tanshinone IIA inhibits cell growth by suppressing SIX1-induced aerobic glycolysis in non-small cell lung cancer cells. Oncol Lett. 2022;23:184.","journal-title":"Oncol Lett"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06290-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T07:49:18Z","timestamp":1741074558000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06290-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6290"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06290-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of The Affiliated Hospital of Xuzhou Medical University (XYFY2022-KL362-01). All animal experiments were approved by the Experimental Animal Ethics Committee of Xuzhou Medical University (202306T001) and conducted in accordance with relevant ethical standards and guidelines. Human Protein Atlas, GEPIA2, Oncomine, STRING, LinkedOmics and CGGA belong to public databases. The patients involved in the database have obtained ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on open source data, so there are no ethical issues and other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}